PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Conducive Government Policies Give Import-dependent GCC Pharmaceutical Market A Makeover Finds Frost & Sullivan - Complimentary Analyst Briefing (Webinar) to be hosted on July 12 at 12:00 pm U.A.E Time will examine the GCC domestic Pharmaceuticals Market against international markets - Pharma.Frost.com
Conducive Government Policies Give Import-dependent GCC Pharmaceutical Market A Makeover Finds Frost & Sullivan

 

NewswireToday - /newswire/ - Dubai, UAE, United Arab Emirates, 2012/07/10 - Complimentary Analyst Briefing (Webinar) to be hosted on July 12 at 12:00 pm U.A.E Time will examine the GCC domestic Pharmaceuticals Market against international markets - Pharma.Frost.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The emerging GCC pharmaceutical market is undergoing a sea change with governments implementing reforms, simplifying regulations and upgrading and expanding healthcare infrastructure to compete with the global pharmaceuticals market. Favourable regulatory policies have attracted foreign participants to the market, intensifying competition among top multinationals and a few local companies.

New analysis from Frost & Sullivan (pharma.frost.com), Strategic Analysis of GCC Pharmaceutical Market Overview and Outlook, finds that the market earned revenues of USD 5.6 billion in 2010 and estimates this to reach USD 10.8 billion in 2020 at a compound annual growth rate (CAGR) of 7.0 per cent. The Pharma Practice at Frost & Sullivan, a Global Growth Partnership Company, is pleased to host an Analyst Briefing (Webinar) on this research service on Thursday, 12th July, 2012 at 12.00 pm. UAE time/ GMT +4.

As imports account for 80 per cent of the GCC pharmaceuticals market, these efforts on part of the governments are vital to enhance local production. Domestic producers focus mainly on the manufacture of generic drugs, but given their high prices, end users tend to lean towards branded drugs.

According to a World Health Organisation (WHO) estimate, drugs in the GCC are priced 13 times higher than the international standard. There is no standardisation in their prices due to the small size of the market and increasing privatisation of the sector.

"The private pharmaceuticals sector in the region favours branded pharmaceuticals and thus, patented drugs dominate the market with around 95.0 per cent share," said Frost & Sullivan Pharma Research Analyst. "While this bodes well for the multinational companies, local manufacturers will be hard pressed to keep pace with the demand for branded drugs."

Governments of GCC countries need to introduce measures to boost domestic manufacturing by engaging with multinational pharmaceutical companies and other stake holders. Their strategies could include offering incentives to new local manufacturers to compete in the growing market while existing participants could be encouraged to introduce improved technologies to survive in the multinational-dominated market.

"GCC governments are trying to reduce their dependence on imports by also entering into joint ventures and licensing deals with multinational pharmaceutical companies," noted Frost & Sullivan Research Analyst. "These initiatives, coupled with the rising incidence of lifestyle diseases in the GCC, are expected to considerably improve the growth rate of the region’s pharmaceutical market."

How will this work:
Click on the 'Register Here' tab, given above. This will direct you to the launch page of the Analyst Briefing. Press on the 'Attend' button; this will register you for the AB. Once you have saved the HTML page, click on it and save the event to your Calendar page.

Strategic Analysis of GCC Pharmaceutical Market Overview and Outlook is part of the Pharmaceuticals & Biotechnology Growth Partnership Services program, which also includes research in the following markets: Strategic Analysis of Contract Research and Manufacturing segment in India. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including research, analysis, strategy, vision, innovation and implementation.
The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us: Start the discussion | Join Us: Join our community | Subscribe: Newsletter on "the next big thing" | Register: Gain access to visionary innovation.

Strategic Analysis of GCC Pharmaceutical Market Overview and Outlook / P59F-52

Contact:
Nimisha Iyer, Corporate Communications - Middle East, North Africa and South Asia
P: +91.98200 50519 / F: +91.22.2832 4713 - E: niyer[.]frost.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Conducive Government Policies Give Import-dependent GCC Pharmaceutical Market A Makeover Finds Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Tanu Chopra / Deepshri Iyer 
+91 9820480089 / +91 2266072038 tanu.chopra[.]frost.com / deepshrii[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  JobsWare.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)